On Rare Disease Day, we stand united in support of those facing the challenges of rare conditions worldwide. At The Hyve, we recognize the hurdles individuals encounter:
🖇 Delayed diagnoses and limited scientific knowledge.
🖇 Inequalities in healthcare access and treatment options.
🖇 Common misdiagnoses due to diverse symptoms.
In our pursuit of breakthroughs, the article written by Anika Bongaarts, “Navigating Druggability in Drug Discovery,” sheds light on the significance of platforms like Open Targets. You can read the article here: https://lnkd.in/eS2wrYxW.
It is already challenging to find proper targets for well-researched diseases, and for rare diseases, the challenge is exponential. That’s where Open Targets can play a crucial role in furthering research by streamlining the identification, validation, and prioritization of drug targets, crucial in the battle against rare diseases. Let’s continue to raise awareness and advocate for increased research and support. Together, we can make strides towards a brighter, healthier future for all! 🌐 #RareDiseaseDay #OpenTargets #Research
Founder & CEO, Project 8p Foundation | Investor | Consultant
3moThank you Cantor for bringing this to the main stage. Over 10,000 rare diseases+...collectively and individually are not so rare anymore with the advancements of genetic testing.